Sean MackayBS, MBA
Sean Mackay is the Co-Founder, Chief Executive Officer and Director of IsoPlexis, a venture capital-funded life sciences company dedicated to accelerating the fight against cancer, autoimmune disease and more through its single-cell proteomics platform. Mr Mackay is an experienced entrepreneur, specializing in the convergence of life sciences and health care delivery. In partnership with co-founders at Yale and Caltech, Mr Mackay led IsoPlexis through foundational licensing and capital raising, while building a scientific and engineering team to develop applications and product.
Previously, Mr Mackay advanced business development at Kleiner Perkins-backed and incubated Lifesquare. Through work at Lazard and several early-stage ventures, he developed deep expertise in structuring and financing life sciences companies. Mr Mackay graduated with a BS in Economics from the University of Pennsylvania’s Wharton School and an MBA from the Yale School of Management.